Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Applied Biosystems CytoScan HD Accel Array

Thermo Fisher Scientific has launched the Applied Biosystems CytoScan HD Accel array, a new chromosomal microarray that the company said will improve cytogenetic research lab productivity, efficiency, and profitability with a two-day turnaround time. Thermo Fisher said the new array, which can analyze the whole human genome and provides improved coverage in more than 5,000 critical genome regions, minimizes sample handling and preparation time. The array requires as little as 100 ng of DNA for input samples and is also compatible with a broad range of sample types, including buccal swabs, saliva, amniotic fluid, chorionic villus, products of conception, and blood.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.